Auris formulations for treating otic diseases and conditions
US-2020230051-A1 · Jul 23, 2020 · US
US12138317B1 · US · B1
| Field | Value |
|---|---|
| Publication number | US-12138317-B1 |
| Application number | US-202418777706-A |
| Country | US |
| Kind code | B1 |
| Filing date | Jul 19, 2024 |
| Priority date | Aug 18, 2017 |
| Publication date | Nov 12, 2024 |
| Grant date | Nov 12, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for enhancing or restoring adhesion to cells that have partially or completely loss the ability to adhere to a substrate or other cells using nanosized clay crystallites.
Opening claim text (preview).
The invention claimed is: 1. A method of increasing cell adhesion, comprising preparing a composition by: sonicating a mixture of nanosized smectite and saline to form the composition, wherein the composition consists of saline and the nanosized smectite, and contacting Raji cells with the composition, wherein the nanosized smectite is palygorskite crystallites having a particle size of 30-75 nm and a cation exchange capacity (CEC) value of about 20 meq/100 g, wherein the contacting results in an increase in adhesion force of the Raji cells to a target substrate of about 200%, compared to a same method but without contacting the Raji cells with the composition, wherein the target substrate is an extracellular matrix (ECM) comprising fibronectin, and wherein the adhesion force is measured between the fibronectin and the Raji cells by atomic force microscopy. 2. The method of claim 1 , wherein the contacting comprises exposing the Raji cells to a concentration of no more than 10 mg/ml of the nanosized smectite in the saline.
Inorganic compounds · CPC title
Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells · CPC title
from inanimate materials (carbon A61K33/44) · CPC title
Iron; Compounds thereof · CPC title
specific for metastasis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.